Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir

Telaprevir (TVR) is an orally available protease inhibitor of the hepatitis C virus that in association with pegylated interferon and ribavirin (PR) was shown to improve the rates of sustained virological response and potentially reduce treatment duration in adult patients with chronic hepatitis C g...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Ambrosio, Roberta, Aghemo, Alessio, Colombo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484502/
https://www.ncbi.nlm.nih.gov/pubmed/23118525
http://dx.doi.org/10.2147/BTT.S20673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484502/
https://www.ncbi.nlm.nih.gov/pubmed/23118525
http://dx.doi.org/10.2147/BTT.S20673

Ejemplares similares